Searchable abstracts of presentations at key conferences in endocrinology

ea0035p915 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Clinical case: Silent corticotroph pituitary macroadenoma transforming into Cushing disease.

Lipatenkova Anna , Dzeranova Larisa , Pigarova Ekaterina , Ektova Anastasia

Introduction: The silent corticotropinomas (SC) account for 1.1–6% of surgically removed pituitary adenomas and 17–22% of ACTH-immunoreactive tumours. They do not cause prominent clinical features of hypercortisolism, nor biochemically evident, but show positive immunostaining for ACTH similar to functional corticotropinomas, They usually present as non-functioning adenomas (NFPA) with local mass effects and/or visual impairment.Aim: To describ...

ea0037ep682 | Pituitary: basic and neuroendocrinology | ECE2015

Granins (chromogranin A, secretogranin II, and secretoneurin) as biochemical and immunohistochemical markers of non-functioning pituitary adenomas

Lipatenkova Anna , Dzeranova Larisa , Pigarova Ekaterina , Astafieva Liudmila , Shishkina Liudmila , Ektova Anastasia

Objective: To assess the sensitivity of granins – chromogranin A (CgA), secretogranin II (SgII), and secretoneurin (Sn) as biochemical and immunohistochemical markers of non-functioning pituitary adenomas (NFPAs):Methods: 50 patients with NFPAs were included in the study. Tissue samples were immunostained for pituitary hormones, Ki-67, αSU, CgA, SgII, and Sn. Furthermore, we have determined the levels of CgA, SgII in the serum and Sn in the pla...